HLA and psoriasis: A genetic study of Northern Italian patients

V. Brazzelli, F. Baldini, F. Borghini, G. L. Nolli, M. Martinetti, C. Pizzochero, M. Cuccia, L. Salvaneschi, C. Tinelli, G. Borroni

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background. We evaluated the HLA association in 40 Italian psoriatic patients. Moreover, combining clinical with immunogenetic heterogeneities by means of the correspondence analysis, we designed a 'disease-map' to facilitate the interpretation of the different HLA profiles. Methods. HLA class I, II and III polymorphisms were studied in 40 Caucasian psoriatic patients. Control group was composed by 118 age-matched blood donors. Results. HLA class I alleles revealed a significant increase of Cw6 in patients (p = 0.00073). HLA class II polymorphism showed that the alleles DR7 and DQ9 were overrepresented in patients (p = 0.00019 and p = 0.00002 respectively). At the genomic level, a significant increase of DRB1*0701, DQA1*0201 and DQB1*0303 in patients was found (p = 0.00052; p = 0.00079 and p = 0.00002, respectively). Analysis of C4A and C4B alleles of the HLA class III showed a significant increase of C4A6 in patients (p = 0.00013). The extended ancestral haplotype (AH 57.1) HLA-A1, Cw6, B57, C4A6, C4B1, DRB1*0701, DQA1*0201, DQB1*0303 was significantly represented in patients (p = 0.000127). In particular, it was increased in females, in familial cases and in patients with palmo-plantar psoriasis. Conclusions. The importance of the contribution of HLA genes is reflected in the evaluation of risk ratio that ranges from 3.08 to 29.79 according to the different alleles or haplotypes considered. Correspondence analysis circumvents the statistical difficulties due to the different, multiple associations between HLA and clinical subtypes. From an immunogenetic perspective, psoriasis adheres closely to a multifactorial model of pathogenesis in which several discrete inherited and environmental factors interact.

Original languageEnglish
Pages (from-to)147-152
Number of pages6
JournalGiornale Italiano di Dermatologia e Venereologia
Volume135
Issue number2
Publication statusPublished - 2000

Fingerprint

Psoriasis
Alleles
Immunogenetics
Haplotypes
HLA-A1 Antigen
Blood Donors
Odds Ratio
Control Groups
Genes

Keywords

  • Disease susceptibility
  • HLA allelles
  • Models, statistical
  • Psoriasis

ASJC Scopus subject areas

  • Dermatology

Cite this

Brazzelli, V., Baldini, F., Borghini, F., Nolli, G. L., Martinetti, M., Pizzochero, C., ... Borroni, G. (2000). HLA and psoriasis: A genetic study of Northern Italian patients. Giornale Italiano di Dermatologia e Venereologia, 135(2), 147-152.

HLA and psoriasis : A genetic study of Northern Italian patients. / Brazzelli, V.; Baldini, F.; Borghini, F.; Nolli, G. L.; Martinetti, M.; Pizzochero, C.; Cuccia, M.; Salvaneschi, L.; Tinelli, C.; Borroni, G.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 135, No. 2, 2000, p. 147-152.

Research output: Contribution to journalArticle

Brazzelli, V, Baldini, F, Borghini, F, Nolli, GL, Martinetti, M, Pizzochero, C, Cuccia, M, Salvaneschi, L, Tinelli, C & Borroni, G 2000, 'HLA and psoriasis: A genetic study of Northern Italian patients', Giornale Italiano di Dermatologia e Venereologia, vol. 135, no. 2, pp. 147-152.
Brazzelli V, Baldini F, Borghini F, Nolli GL, Martinetti M, Pizzochero C et al. HLA and psoriasis: A genetic study of Northern Italian patients. Giornale Italiano di Dermatologia e Venereologia. 2000;135(2):147-152.
Brazzelli, V. ; Baldini, F. ; Borghini, F. ; Nolli, G. L. ; Martinetti, M. ; Pizzochero, C. ; Cuccia, M. ; Salvaneschi, L. ; Tinelli, C. ; Borroni, G. / HLA and psoriasis : A genetic study of Northern Italian patients. In: Giornale Italiano di Dermatologia e Venereologia. 2000 ; Vol. 135, No. 2. pp. 147-152.
@article{9c39e5f76db048df88dc71346b200a2b,
title = "HLA and psoriasis: A genetic study of Northern Italian patients",
abstract = "Background. We evaluated the HLA association in 40 Italian psoriatic patients. Moreover, combining clinical with immunogenetic heterogeneities by means of the correspondence analysis, we designed a 'disease-map' to facilitate the interpretation of the different HLA profiles. Methods. HLA class I, II and III polymorphisms were studied in 40 Caucasian psoriatic patients. Control group was composed by 118 age-matched blood donors. Results. HLA class I alleles revealed a significant increase of Cw6 in patients (p = 0.00073). HLA class II polymorphism showed that the alleles DR7 and DQ9 were overrepresented in patients (p = 0.00019 and p = 0.00002 respectively). At the genomic level, a significant increase of DRB1*0701, DQA1*0201 and DQB1*0303 in patients was found (p = 0.00052; p = 0.00079 and p = 0.00002, respectively). Analysis of C4A and C4B alleles of the HLA class III showed a significant increase of C4A6 in patients (p = 0.00013). The extended ancestral haplotype (AH 57.1) HLA-A1, Cw6, B57, C4A6, C4B1, DRB1*0701, DQA1*0201, DQB1*0303 was significantly represented in patients (p = 0.000127). In particular, it was increased in females, in familial cases and in patients with palmo-plantar psoriasis. Conclusions. The importance of the contribution of HLA genes is reflected in the evaluation of risk ratio that ranges from 3.08 to 29.79 according to the different alleles or haplotypes considered. Correspondence analysis circumvents the statistical difficulties due to the different, multiple associations between HLA and clinical subtypes. From an immunogenetic perspective, psoriasis adheres closely to a multifactorial model of pathogenesis in which several discrete inherited and environmental factors interact.",
keywords = "Disease susceptibility, HLA allelles, Models, statistical, Psoriasis",
author = "V. Brazzelli and F. Baldini and F. Borghini and Nolli, {G. L.} and M. Martinetti and C. Pizzochero and M. Cuccia and L. Salvaneschi and C. Tinelli and G. Borroni",
year = "2000",
language = "English",
volume = "135",
pages = "147--152",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - HLA and psoriasis

T2 - A genetic study of Northern Italian patients

AU - Brazzelli, V.

AU - Baldini, F.

AU - Borghini, F.

AU - Nolli, G. L.

AU - Martinetti, M.

AU - Pizzochero, C.

AU - Cuccia, M.

AU - Salvaneschi, L.

AU - Tinelli, C.

AU - Borroni, G.

PY - 2000

Y1 - 2000

N2 - Background. We evaluated the HLA association in 40 Italian psoriatic patients. Moreover, combining clinical with immunogenetic heterogeneities by means of the correspondence analysis, we designed a 'disease-map' to facilitate the interpretation of the different HLA profiles. Methods. HLA class I, II and III polymorphisms were studied in 40 Caucasian psoriatic patients. Control group was composed by 118 age-matched blood donors. Results. HLA class I alleles revealed a significant increase of Cw6 in patients (p = 0.00073). HLA class II polymorphism showed that the alleles DR7 and DQ9 were overrepresented in patients (p = 0.00019 and p = 0.00002 respectively). At the genomic level, a significant increase of DRB1*0701, DQA1*0201 and DQB1*0303 in patients was found (p = 0.00052; p = 0.00079 and p = 0.00002, respectively). Analysis of C4A and C4B alleles of the HLA class III showed a significant increase of C4A6 in patients (p = 0.00013). The extended ancestral haplotype (AH 57.1) HLA-A1, Cw6, B57, C4A6, C4B1, DRB1*0701, DQA1*0201, DQB1*0303 was significantly represented in patients (p = 0.000127). In particular, it was increased in females, in familial cases and in patients with palmo-plantar psoriasis. Conclusions. The importance of the contribution of HLA genes is reflected in the evaluation of risk ratio that ranges from 3.08 to 29.79 according to the different alleles or haplotypes considered. Correspondence analysis circumvents the statistical difficulties due to the different, multiple associations between HLA and clinical subtypes. From an immunogenetic perspective, psoriasis adheres closely to a multifactorial model of pathogenesis in which several discrete inherited and environmental factors interact.

AB - Background. We evaluated the HLA association in 40 Italian psoriatic patients. Moreover, combining clinical with immunogenetic heterogeneities by means of the correspondence analysis, we designed a 'disease-map' to facilitate the interpretation of the different HLA profiles. Methods. HLA class I, II and III polymorphisms were studied in 40 Caucasian psoriatic patients. Control group was composed by 118 age-matched blood donors. Results. HLA class I alleles revealed a significant increase of Cw6 in patients (p = 0.00073). HLA class II polymorphism showed that the alleles DR7 and DQ9 were overrepresented in patients (p = 0.00019 and p = 0.00002 respectively). At the genomic level, a significant increase of DRB1*0701, DQA1*0201 and DQB1*0303 in patients was found (p = 0.00052; p = 0.00079 and p = 0.00002, respectively). Analysis of C4A and C4B alleles of the HLA class III showed a significant increase of C4A6 in patients (p = 0.00013). The extended ancestral haplotype (AH 57.1) HLA-A1, Cw6, B57, C4A6, C4B1, DRB1*0701, DQA1*0201, DQB1*0303 was significantly represented in patients (p = 0.000127). In particular, it was increased in females, in familial cases and in patients with palmo-plantar psoriasis. Conclusions. The importance of the contribution of HLA genes is reflected in the evaluation of risk ratio that ranges from 3.08 to 29.79 according to the different alleles or haplotypes considered. Correspondence analysis circumvents the statistical difficulties due to the different, multiple associations between HLA and clinical subtypes. From an immunogenetic perspective, psoriasis adheres closely to a multifactorial model of pathogenesis in which several discrete inherited and environmental factors interact.

KW - Disease susceptibility

KW - HLA allelles

KW - Models, statistical

KW - Psoriasis

UR - http://www.scopus.com/inward/record.url?scp=0033935243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033935243&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033935243

VL - 135

SP - 147

EP - 152

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 2

ER -